Beth Apsel Winger

Beth Apsel Winger is a clinical researcher at the University of California San Francisco (UCSF), focusing on precision medicine for cancer and blood diseases. Her work bridges targeted therapies and pharmacokinetics to optimize drug dosing.

• Education: BA in Chemistry (Yale), PhD in Chemistry & Chemical Biology (UCSF), MD (UCSF), Residency in Pediatrics (UCSF), Fellowship in Pediatric Hematology/Oncology (UCSF)

Her research explores kinase mutations to expand targeted therapies and precision dosing strategies for individualized treatment. Recent work includes genomic sequencing applications in leukemia and pharmacokinetic modeling for pediatric transplantation.

Scientific Awards include the Fulbright Graduate Student Award, St. Baldrick's Foundation Fellowship, Mary Anne Koda-Kimble Award for Innovation, and Helen Diller Family Comprehensive Cancer Center Junior Clinical Investigator Award.

She collaborates on grants and clinical initiatives, such as the LEAP Consortium for pediatric leukemia therapies and precision dosing platforms. Her expertise spans pediatric hematology/oncology, molecular oncology, and pharmacogenomics.